RecruitingNCT06344208

Predicting Toxicity in Elderly Patients With Head and Neck Cancer

Predicting Toxicity in Elderly Patients With Head and Neck Cancer: Validating a Disease-oriented Toxicity Predictive Tool and Integrating it With Available Screening Tools for Better Outcomes


Sponsor

European Institute of Oncology

Enrollment

3 participants

Start Date

Mar 15, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Predicting toxicity in elderly patients with head and neck cancer: validating a disease-oriented toxicity predictive tool and integrating it with avail-able screening tools for better outcomes.


Eligibility

Min Age: 70 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study aims to predict which older patients with head and neck cancer are most likely to experience serious side effects from radiation treatment. By identifying these patients ahead of time, doctors can better tailor treatment plans to protect their health. **You may be eligible if...** - You are 70 years old or older - You have been diagnosed with squamous cell or undifferentiated head and neck cancer (such as cancer of the mouth, throat, voice box, or nasal passages) at stage III or IV - Your treatment plan involves radiation therapy, with or without chemotherapy or a drug called cetuximab (non-surgical treatment) - Your cancer can be measured on scans **You may NOT be eligible if...** - You have had another cancer (other than certain low-risk cancers like early prostate cancer or skin cancer) in the past 2 years - You are in very poor physical condition (ECOG score of 3–4, meaning you are mostly confined to bed) - You have previously been treated with systemic therapy for a different primary tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

European Institute of Oncology

Milan, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06344208


Related Trials